Newsroom

[Kaiser Health News] ‘National Dialogue’ Urged On Cost Of New Hepatitis C Drug

“The outcry continues over the $1,000-a-pill hepatitis C drug made by California-based Gilead Sciences. While the drug is a significant advance over older treatments for the […]

Read more

[Vox.com] The fiercest debate in health care is about a $1,000 pill

“The people who pay for drugs aren’t fully buying those arguments — and want Sovaldi to back off its prices. They argue that Gilead could more […]

Read more

[MedPage Today] Medicaid Directors Question Need for $1,000 HCV Pill

By Michael Smith May 22, 2014   The evidence base for one of the star hepatitis C drugs is poor and the guidelines for its use […]

Read more

[CNBC] The $84,000 question: Will focusing on drug prices rein in costs?

By Meg Tirrell May 22, 2014   The mounting scrutiny of prescription drug prices in the U.S. reached fever pitch when a new drug for hepatitis […]

Read more